期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 52, 期 3, 页码 1179-1181出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01108-07
关键词
-
资金
- NCRR NIH HHS [M01 RR000052, RR00052] Funding Source: Medline
Rifaximin is an oral antibiotic indicated for treatment of traveler's diarrhea. Rifaximin pharmacokinetics were evaluated in individuals challenged with Shigella flexneri. Peak plasma rifaximin concentrations were low after nine consecutive doses, and no accumulation was observed. Rifaximin serum levels were minimal and similar to those previously reported in studies of healthy volunteers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据